FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

February 24, 2016

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for Interoperable Medical Devices.”

On January 26, 2016, the FDA published a draft guidance entitledDesign Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices.”  The document provides medical device manufacturers with assistance regarding product design and labeling of interoperable devices.

Interoperable medical devices are two or more devices that exchange data and information in a safe and effective manner. The ability to do this is a growing need within the healthcare industry, which is what drove the FDA to develop this draft guidance.

When the draft guidance was released in late January, the FDA asked interested persons to submit comments and suggestions by March 28, 2016. In response to a number of requests for an extension, on February 23rd, the FDA announced that the comment period will remain open for an additional 30 days. As such, interested persons should submit comments, questions, and/or concerns by April 28, 2016.

Do you manufacture a medical device or any other type of FDA-regulated product? We can help ensure that your product is compliant with all requirements. For additional information on how we can help you, contact us today.



Agency Alerts

February 24, 2016

FDA Revokes Emergency Use Authorization of IVD Device for COVID-19 Detection

On Wednesday, October 27th, FDA revoked Life Technologies Corporation’s Emergency Use Authorization (EUA) for its TaqPath COVID-19 MS2 Combo Kit 2.0. Background On August 2, 2021, FDA issued an EUA...

Read More
Medical Device Agency Alerts

February 24, 2016

FDA Considers Moving Medical Device Submissions to Electronic Format

On Thursday, September 13th, FDA published a proposed rule which would amend the current premarket submission requirements for medical devices. Background In July 2012, the Food and Drug...

Read More
Agency Alerts General Regulatory

February 24, 2016

Will FDA Change the Definition of “Intended Use”?

FDA released proposed regulation that would allow sponsors to determine if their product is a drug/device, or if it is not a drug/device. Last week, the Agency announced a proposed rule “to provide...

Read More